AXDX
AXDX Real Time Price USDRecent trades of AXDX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AXDX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$10,000 Nov 06, 2017 Issue: Medical/Disease Research/Clinical Labs Science/Technology
-
$10,000 Jul 17, 2017 Issue: Science/Technology
Estimated quarterly lobbying spending
AXDX Revenue by Segment or Geography
New patents grants
-
Patent Title: Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing Mar. 26, 2024
-
Patent Title: Rapid determination of microbial growth and antimicrobial susceptibility Mar. 14, 2023
-
Patent Title: Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing Aug. 10, 2021
-
Patent Title: Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing Aug. 03, 2021
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Jul. 06, 2021
-
Patent Title: Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing Apr. 30, 2019
-
Patent Title: Membrane-assisted purification Apr. 09, 2019
-
Patent Title: Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing Apr. 09, 2019
-
Patent Title: Rapid cell purification systems Feb. 12, 2019
-
Patent Title: Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing Jul. 17, 2018
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Dec. 12, 2017
-
Patent Title: Cartridge Oct. 03, 2017
-
Patent Title: Rapid cell purification systems Jul. 25, 2017
-
Patent Title: Rapid determination of microbial growth and antimicrobial susceptibility Jun. 13, 2017
-
Patent Title: Rapid microbial detection and antimicrobial susceptibility testing May. 23, 2017
-
Patent Title: Cartridge Dec. 06, 2016
-
Patent Title: Cassette Dec. 06, 2016
-
Patent Title: Rapid cell purification systems Sep. 06, 2016
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Nov. 25, 2014
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Jun. 11, 2013
Federal grants, loans, and purchases
- $57,585 2025-04-24 00:00:00 Agency: Department of Veterans Affairs
- $110,100 2024-04-24 00:00:00 Agency: Department of Veterans Affairs
- $57,585 2024-04-19 00:00:00 Agency: Department of Veterans Affairs
- $57,189 2023-11-17 00:00:00 Agency: Department of Veterans Affairs
- $110,100 2023-06-08 00:00:00 Agency: Department of Veterans Affairs
- $57,386 2023-05-17 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-05-03 00:00:00 Agency: Department of Veterans Affairs
- $110,100 2022-06-03 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $134,385 2022-01-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $10,900 2021-10-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $55,276 2021-08-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $166,200 2021-08-12 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $110,100 2021-06-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Recent insights relating to AXDX
Recent picks made for AXDX stock on CNBC
ETFs with the largest estimated holdings in AXDX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $AXDX stock a Buy, Sell, or Hold?
- What is the price target for $AXDX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $AXDX stock?
- Who owns the most shares of $AXDX stock?
- What funds own $AXDX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AXDX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.